CS273602B2 - Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation - Google Patents

Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation Download PDF

Info

Publication number
CS273602B2
CS273602B2 CS920184A CS920184A CS273602B2 CS 273602 B2 CS273602 B2 CS 273602B2 CS 920184 A CS920184 A CS 920184A CS 920184 A CS920184 A CS 920184A CS 273602 B2 CS273602 B2 CS 273602B2
Authority
CS
Czechoslovakia
Prior art keywords
group
azabicyclo
formula
methyl
dimethylamino
Prior art date
Application number
CS920184A
Other languages
Czech (cs)
English (en)
Other versions
CS920184A2 (en
Inventor
Karoly Dr Ing Nador
Gabor Dr Kraiss
Margit Dr Pellionisz
Egon Dr Karpati
Laszlo Dr Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to CS599389A priority Critical patent/CS273650B2/cs
Publication of CS920184A2 publication Critical patent/CS920184A2/cs
Publication of CS273602B2 publication Critical patent/CS273602B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CS920184A 1983-11-30 1984-11-29 Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation CS273602B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS599389A CS273650B2 (en) 1983-11-30 1989-10-23 Preparation of new derivatives azabicyclo-/3,3,1/nonane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834096A HU190511B (en) 1983-11-30 1983-11-30 Process for preparing new azabicyclic compounds

Publications (2)

Publication Number Publication Date
CS920184A2 CS920184A2 (en) 1990-08-14
CS273602B2 true CS273602B2 (en) 1991-03-12

Family

ID=10966876

Family Applications (1)

Application Number Title Priority Date Filing Date
CS920184A CS273602B2 (en) 1983-11-30 1984-11-29 Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation

Country Status (31)

Country Link
US (1) US4769373A (da)
JP (1) JPS60185766A (da)
AR (1) AR241492A1 (da)
AT (1) AT388730B (da)
AU (1) AU570285B2 (da)
BE (1) BE901174A (da)
CA (1) CA1280751C (da)
CH (1) CH663615A5 (da)
CS (1) CS273602B2 (da)
DD (1) DD231073A1 (da)
DE (1) DE3442365A1 (da)
DK (1) DK568584A (da)
EG (1) EG16845A (da)
ES (2) ES8604579A1 (da)
FI (1) FI80445C (da)
FR (1) FR2555580B1 (da)
GB (1) GB2150558B (da)
GR (1) GR81084B (da)
HU (1) HU190511B (da)
IL (1) IL73421A (da)
IT (1) IT1178638B (da)
MX (1) MX157611A (da)
NL (1) NL8403634A (da)
NO (1) NO165292C (da)
PH (1) PH19659A (da)
PL (2) PL144546B1 (da)
PT (1) PT79568B (da)
SE (1) SE460418B (da)
SU (1) SU1395141A3 (da)
YU (1) YU45681B (da)
ZA (1) ZA848721B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525672D0 (en) * 2005-12-16 2006-01-25 Novartis Ag Organic compounds
CN111187210B (zh) * 2020-01-08 2022-05-03 成都中医药大学 一种热解型二萜生物碱化合物及其制备方法和用途
CN113149905B (zh) * 2021-02-24 2022-04-29 成都中医药大学 一种抗心律失常的化合物及其制药用途
CN113149906B (zh) * 2021-02-24 2022-05-17 成都中医药大学 一种抗心律失常药物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195746A (en) * 1967-06-07 1970-06-24 Yoshitomi Pharmaceutical 3-Azabicyclo [3,3,1] Nonane Derivatives
US3741973A (en) * 1967-09-11 1973-06-26 Upjohn Co Oxygenated 3-azabicyclo(3.3.1)nonanes
GB1393253A (en) * 1971-09-10 1975-05-07 Wyeth John & Brother Ltd 3-azabicyclo-3,3,1-nonanes

Also Published As

Publication number Publication date
PL254457A1 (en) 1987-03-23
AU3602984A (en) 1985-06-06
NO165292C (no) 1991-01-23
GB2150558B (en) 1987-10-14
PH19659A (en) 1986-06-09
PT79568B (en) 1986-09-11
FI80445C (fi) 1990-06-11
YU200684A (en) 1987-10-31
GB2150558A (en) 1985-07-03
IT8423805A0 (it) 1984-11-29
EG16845A (en) 1990-12-30
ES538069A0 (es) 1986-02-01
PL250635A1 (en) 1985-11-05
CA1280751C (en) 1991-02-26
NL8403634A (nl) 1985-06-17
ES8606338A1 (es) 1986-04-01
SU1395141A3 (ru) 1988-05-07
IL73421A (en) 1987-12-31
PL142604B1 (en) 1987-11-30
DK568584D0 (da) 1984-11-29
NO165292B (no) 1990-10-15
US4769373A (en) 1988-09-06
SE460418B (sv) 1989-10-09
AU570285B2 (en) 1988-03-10
FI844480A0 (fi) 1984-11-15
SE8406046L (sv) 1985-05-31
ES548112A0 (es) 1986-04-01
BE901174A (fr) 1985-05-30
FI80445B (fi) 1990-02-28
NO844750L (no) 1985-05-31
PT79568A (en) 1984-12-01
PL144546B1 (en) 1988-06-30
CS920184A2 (en) 1990-08-14
HUT35647A (en) 1985-07-29
ES8604579A1 (es) 1986-02-01
DK568584A (da) 1985-05-31
ATA352184A (de) 1989-01-15
JPS60185766A (ja) 1985-09-21
YU45681B (sh) 1992-07-20
DE3442365A1 (de) 1985-06-05
IT1178638B (it) 1987-09-09
GB8428143D0 (en) 1984-12-12
DD231073A1 (de) 1985-12-18
CH663615A5 (de) 1987-12-31
HU190511B (en) 1986-09-29
FR2555580A1 (fr) 1985-05-31
AR241492A1 (es) 1992-07-31
SE8406046D0 (sv) 1984-11-29
ZA848721B (en) 1985-06-26
GR81084B (en) 1985-03-29
MX157611A (es) 1988-12-05
FI844480L (fi) 1985-05-31
FR2555580B1 (fr) 1988-10-28
AT388730B (de) 1989-08-25

Similar Documents

Publication Publication Date Title
Clarke et al. Compounds affecting the central nervous system. 4. 3. beta.-phenyltropane-2-carboxylic esters and analogs
EP0975595B1 (en) Analogs of cocaine
KR0168432B1 (ko) 아미노 알콜의 티에닐카복실레이트, 이의 4급 생성물, 이들 화합물의 제조방법 및 이들 화합물을 함유하는 약제
US4587253A (en) Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4482556A (en) Pyrimido (6,1-a)isoquinolin-4-one derivatives
HU178532B (en) Process for producing 1,2,4,5-tetraalkyl-4-aryl-piperidine derivatives
US4277476A (en) Derivatives of fluorenes and fluoranthenes and process for their preparation
CS273602B2 (en) Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation
GB1571511A (en) Fused quinuclidine derivatives and pharmaceutical compositions containing them
Yamato et al. Synthesis and structure-activity relationship of spiro [isochromanpiperidine] analogs for inhibition of histamine release. 1
WO1985000169A1 (en) 1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them
KR870001681B1 (ko) 히단토인 유도체의 제조방법
US6258829B1 (en) Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
US4451473A (en) 3,7-Diazabicyclo [3.3.1] nonanes having anti-arrhythmic activity
EP0657455A1 (en) Epi-epibatidine derivatives, a process and intermediates for preparing them and epi-epibatidine and medicaments containing the epi-epibatidine derivatives and/or epi-epibatidine and the use of them
US3974285A (en) 10,11-Furo-derivatives of cyproheptadine
US4044143A (en) 10,11-Bis-(hydroxyalkyl) derivatives of cyproheptadine
EP0264232A1 (en) 2-Azetidinone derivatives
US4593033A (en) Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
US4015002A (en) 1-Aryl-2-oxo-2,4,5,6,7,7a-hexahydro-indoles, salts, pharmaceutical compositions and methods of use
US4062956A (en) Substituted 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines and quaternary salts thereof useful for treating spasmodic syndromes
US4271161A (en) Indane-acetic acid aminoesters, their preparation and their use in therapy
US4070468A (en) 2-Amino-quinolin-4-one-3-phosphonic acid esters
US4226996A (en) Novel heterocyclic compounds and pharmaceutical composition containing them
US2802826A (en) Octahydro-pyrido [4, 3-d] pyrimidine compounds